Stock listing
Bioaffinity Technologies, Inc.
Selected listing: BIAF · NASDAQ · USD · US
Bioaffinity Technologies, Inc. (NASDAQ:BIAF), Health Technology. Latest release Oct 6, 2026: bioAffinity Technologies Reports Over 100% Growth in CyPath® Lung…
- Ticker
- NASDAQ:BIAF
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- NASDAQ
- Currency
- USD
About Bioaffinity Technologies, Inc.
The company focuses on developing innovative technologies in the healthcare sector. Its efforts aim to improve diagnostic and therapeutic solutions for various medical conditions.
Latest news from Bioaffinity Technologies, Inc.
bioAffinity Technologies Reports Over 100% Growth in CyPath® Lung Sales Through Third Quarter 2026
October 6, 2026
BioAffinity Technologies Promotes Veteran Awareness and Access to Its Noninvasive CyPath® Lung Cancer Test Through Distribution Partnership with Veteran-Owned AvMEDICAL
September 30, 2026
BioAffinity Technologies to Present Positive Clinical and Veteran-Focused Data on CyPath® Lung at NAVREF 2026 Annual Conference
September 22, 2026
BioAffinity Technologies Announces Grant of Hong Kong Patent for Company's CyPath(R) Lung Noninvasive Lung Cancer Diagnostic
September 18, 2026
BioAffinity Technologies Announces Grant of Hong Kong Patent for Company's CyPath® Lung Noninvasive Lung Cancer Diagnostic
September 17, 2026
Events
Research Bioaffinity Technologies, Inc.
Bioaffinity Technologies, Inc. company profile
View the public company page for Bioaffinity Technologies, Inc. on 6ix.
Bioaffinity Technologies, Inc. news
Read company news and market updates connected to Bioaffinity Technologies, Inc..
Bioaffinity Technologies, Inc. investor events
Find investor webinars, events, and replay context for Bioaffinity Technologies, Inc..